Search Results:
CLINICAL TRIAL 18994
Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing
Disease Site: Lip, Oral Cavity and Pharynx, Larynx, Head & Neck
View Trial DetailsCLINICAL TRIAL 19473
Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin
Disease Site: Other Endocrine System, Head & Neck
View Trial DetailsCLINICAL TRIAL 19570
A Phase II Trial of Pembrolizumab and Cabozantinib in Patients with RM SCCHN
Disease Site: Other Endocrine System, Head & Neck
View Trial DetailsCLINICAL TRIAL 19748
Phase II Randomized Trial of Radiotherapy with Concurrent and Adjuvant Pembrolizumab (Keytruda®) Versus Concurrent Chemotherapy in Patients with Advanced/Intermediate-Risk p16+ Head and Neck Squamous Cell Carcinoma (KEYCHAIN Trial)
Disease Site: Lip, Oral Cavity and Pharynx, Other Skin, Head & Neck, Squamous Cell Carcinoma (SCC)
View Trial DetailsCLINICAL TRIAL 19855
The AIM-HN and SEQ-HN Study: A 2 Cohort, Non-comparative, Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma(HNSCC) with HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First Line Systemic Therapies for HNSCC (SEQ-HN)
Disease Site: Lip, Oral Cavity and Pharynx, Larynx, Head & Neck, Squamous Cell Carcinoma (SCC)
View Trial DetailsCLINICAL TRIAL 20114
A Single Arm Phase II Study of Cemiplimab-rwlc in Immunocompromised Patients with Unresectable Locally Recurrent and/or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)
Disease Site: Other Head & Neck, Other Skin, Skin, Squamous Cell Carcinoma (SCC)
View Trial DetailsCLINICAL TRIAL 20144
A Phase 1, First-in-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second Line and CUE-101 Combination Therapy with Pembrolizumab in First Line Patients with HPV16+ Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
Disease Site: Head & Neck, Larynx, Lip, Oral Cavity and Pharynx, Squamous Cell Carcinoma (SCC)
View Trial DetailsCLINICAL TRIAL 20485
A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment
Disease Site: Any Site, Head & Neck, Larynx, Mouth, lip, nasal cavity, Throat
View Trial DetailsCLINICAL TRIAL 20845
Health Insurance Literacy in Head and Neck Cancer Patients
Disease Site: Esophageal (Throat), Head & Neck, Larynx, Lip, Oral Cavity and Pharynx, Mouth, lip, nasal cavity, Pharynx
View Trial DetailsCLINICAL TRIAL 21079
Head and Neck Cancer Pre-Surgery Education and Discharge Planning: Key Stakeholder Perceptions
Disease Site: Head & Neck, Larynx, Lip, Oral Cavity and Pharynx
View Trial Details